Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Retained Earnings (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Retained Earnings for 16 consecutive years, with $608.1 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 10333.73% to $608.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $608.1 million through Dec 2025, up 10333.73% year-over-year, with the annual reading at $608.1 million for FY2025, 10333.73% up from the prior year.
  • Retained Earnings hit $608.1 million in Q4 2025 for Ligand Pharmaceuticals, up from $9.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $608.1 million in Q4 2025 to a low of -$5.9 million in Q4 2024.
  • Historically, Retained Earnings has averaged $321.3 million across 5 years, with a median of $459.0 million in 2025.
  • Biggest five-year swings in Retained Earnings: skyrocketed 54870.79% in 2022 and later tumbled 101.18% in 2024.
  • Year by year, Retained Earnings stood at -$917000.0 in 2021, then dropped by 7.31% to -$984000.0 in 2022, then surged by 51219.51% to $503.0 million in 2023, then crashed by 101.18% to -$5.9 million in 2024, then soared by 10333.73% to $608.1 million in 2025.
  • Business Quant data shows Retained Earnings for LGNDZ at $608.1 million in Q4 2025, $9.3 million in Q3 2025, and $461.4 million in Q2 2025.